Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S Maryland Ave, Chicago, IL, 60637, USA.
Department of Psychiatry and Biobehavioral Sciences, University of Los Angeles, California, 760 Westwood Plaza, Los Angeles, CA, 90024, USA.
Neuropsychopharmacology. 2024 Jun;49(7):1120-1128. doi: 10.1038/s41386-024-01809-2. Epub 2024 Jan 29.
Neural complexity correlates with one's level of consciousness. During coma, anesthesia, and sleep, complexity is reduced. During altered states, including after lysergic acid diethylamide (LSD), complexity is increased. In the present analysis, we examined whether low doses of LSD (13 and 26 µg) were sufficient to increase neural complexity in the absence of altered states of consciousness. In addition, neural complexity was assessed after doses of two other drugs that significantly altered consciousness and mood: delta-9-tetrahydrocannabinol (THC; 7.5 and 15 mg) and methamphetamine (MA; 10 and 20 mg). In three separate studies (N = 73; 21, LSD; 23, THC; 29, MA), healthy volunteers received placebo or drug in a within-subjects design over three laboratory visits. During anticipated peak drug effects, resting state electroencephalography (EEG) recorded Limpel-Ziv complexity and spectral power. LSD, but not THC or MA, dose-dependently increased neural complexity. LSD also reduced delta and theta power. THC reduced, and MA increased, alpha power, primarily in frontal regions. Neural complexity was not associated with any subjective drug effect; however, LSD-induced reductions in delta and theta were associated with elation, and THC-induced reductions in alpha were associated with altered states. These data inform relationships between neural complexity, spectral power, and subjective states, demonstrating that increased neural complexity is not necessary or sufficient for altered states of consciousness. Future studies should address whether greater complexity after low doses of LSD is related to cognitive, behavioral, or therapeutic outcomes, and further examine the role of alpha desynchronization in mediating altered states of consciousness.
神经复杂性与一个人的意识水平相关。在昏迷、麻醉和睡眠期间,复杂性会降低。在改变的状态下,包括在麦角酸二乙酰胺(LSD)之后,复杂性会增加。在本分析中,我们研究了低剂量 LSD(13 和 26μg)是否足以在没有改变意识状态的情况下增加神经复杂性。此外,在两种其他显著改变意识和情绪的药物剂量后评估了神经复杂性:Delta-9-四氢大麻酚(THC;7.5 和 15mg)和甲基苯丙胺(MA;10 和 20mg)。在三个独立的研究中(N=73;21 个 LSD,23 个 THC,29 个 MA),健康志愿者在三个实验室访问中接受了安慰剂或药物的在体设计。在预期的药物峰值效应期间,静息状态脑电图(EEG)记录了 Limpel-Ziv 复杂性和光谱功率。LSD 但不是 THC 或 MA 剂量依赖性地增加了神经复杂性。LSD 还降低了 delta 和 theta 功率。THC 降低了,MA 增加了,主要在前额区域增加了 alpha 功率。神经复杂性与任何主观药物效应无关;然而,LSD 诱导的 delta 和 theta 减少与兴奋有关,而 THC 诱导的 alpha 减少与改变的状态有关。这些数据提供了神经复杂性、光谱功率和主观状态之间的关系信息,表明增加的神经复杂性对于意识状态的改变不是必要的或充分的。未来的研究应该解决低剂量 LSD 后增加的复杂性是否与认知、行为或治疗结果有关,并进一步研究 alpha 去同步化在介导意识状态改变中的作用。